Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $67.7700 (0.85%) ($67.7700 - $68.3900) on Tue. Jan. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.01% (three month average) | RSI | 59 | Latest Price | $67.7700(0.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.6% a day on average for past five trading days. | Weekly Trend | LGND advances 0.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(48%) IWN(48%) XBI(48%) IWC(47%) IWO(47%) | Factors Impacting LGND price | LGND will decline at least -2.005% in a week (0% probabilities). VIXM(-24%) SHY(-17%) IGOV(-7%) UUP(-6%) BNDX(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.005% (StdDev 4.01%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $66.69(1.62%) | 10 Day Moving Average | $66.58(1.79%) | 20 Day Moving Average | $65.57(3.36%) | To recent high | -28.1% | To recent low | 9.6% | Market Cap | $1.089b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |